Enovis Gross Margin 2010-2023 | ENOV
Current and historical gross margin for Enovis (ENOV) over the last 10 years. The current gross profit margin for Enovis as of December 31, 2023 is %.
| Enovis Gross Margin Historical Data | |||
|---|---|---|---|
| Date | TTM Revenue | TTM Gross Profit | Gross Margin |
| 2023-12-31 | $1.71B | $0.99B | 57.96% |
| 2023-09-30 | $1.66B | $0.96B | 57.64% |
| 2023-06-30 | $1.63B | $0.93B | 57.19% |
| 2023-03-31 | $1.59B | $0.90B | 56.40% |
| 2022-12-31 | $1.56B | $0.87B | 55.66% |
| 2022-09-30 | $0.99B | $0.65B | 65.58% |
| 2022-06-30 | $0.96B | $0.63B | 65.35% |
| 2022-03-31 | $0.92B | $0.61B | 66.49% |
| 2021-12-31 | $1.43B | $0.78B | 54.56% |
| 2021-09-30 | $0.47B | $0.44B | 93.02% |
| 2021-06-30 | $0.92B | $0.59B | 63.76% |
| 2021-03-31 | $1.18B | $0.63B | 52.92% |
| 2020-12-31 | $1.12B | $0.60B | 53.84% |
| 2020-09-30 | $3.13B | $1.33B | 42.46% |
| 2020-06-30 | $3.17B | $1.35B | 42.67% |
| 2020-03-31 | $3.46B | $1.49B | 43.01% |
| 2019-12-31 | $3.33B | $1.40B | 42.10% |
| 2019-09-30 | $2.67B | $1.10B | 41.28% |
| 2019-06-30 | $2.34B | $0.90B | 38.57% |
| 2019-03-31 | $2.00B | $0.72B | 36.07% |
| 2018-12-31 | $2.19B | $0.73B | 33.29% |
| 2018-09-30 | $1.48B | $0.54B | 36.83% |
| 2018-06-30 | $1.80B | $0.64B | 35.43% |
| 2018-03-31 | $2.09B | $0.70B | 33.72% |
| 2017-12-31 | $1.94B | $0.67B | 34.67% |
| 2017-09-30 | $3.01B | $0.93B | 31.01% |
| 2017-06-30 | $2.93B | $0.91B | 30.95% |
| 2017-03-31 | $3.04B | $0.95B | 31.25% |
| 2016-12-31 | $3.19B | $0.99B | 31.14% |
| 2016-09-30 | $3.13B | $0.97B | 31.09% |
| 2016-06-30 | $3.33B | $1.03B | 30.94% |
| 2016-03-31 | $3.40B | $1.06B | 31.12% |
| 2015-12-31 | $3.43B | $1.07B | 31.19% |
| 2015-09-30 | $4.11B | $1.31B | 31.87% |
| 2015-06-30 | $4.31B | $1.39B | 32.21% |
| 2015-03-31 | $4.48B | $1.45B | 32.30% |
| 2014-12-31 | $4.62B | $1.48B | 31.99% |
| 2014-09-30 | $4.59B | $1.44B | 31.47% |
| 2014-06-30 | $4.44B | $1.39B | 31.34% |
| 2014-03-31 | $4.31B | $1.34B | 31.08% |
| 2013-12-31 | $4.21B | $1.31B | 31.04% |
| 2013-09-30 | $4.06B | $1.26B | 30.94% |
| 2013-06-30 | $4.00B | $1.23B | 30.61% |
| 2013-03-31 | $3.97B | $1.20B | 30.25% |
| 2012-12-31 | $3.91B | $1.15B | 29.47% |
| 2012-09-30 | $3.06B | $0.91B | 29.60% |
| 2012-06-30 | $2.28B | $0.68B | 29.82% |
| 2012-03-31 | $1.42B | $0.43B | 30.26% |
| 2011-12-31 | $0.69B | $0.24B | 34.73% |
| 2011-09-30 | $0.68B | $0.24B | 34.99% |
| 2011-06-30 | $0.65B | $0.23B | 34.88% |
| 2011-03-31 | $0.58B | $0.20B | 34.94% |
| 2010-12-31 | $0.54B | $0.19B | 35.42% |
| 2010-09-30 | $0.51B | $0.18B | 35.38% |
| 2010-06-30 | $0.50B | $0.18B | 35.39% |
| 2010-03-31 | $0.51B | $0.18B | 35.36% |
| 2009-12-31 | $0.53B | $0.19B | 35.43% |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Information Systems | $3.030B | $1.707B |
| Enovis Corporation is a medical technology company. Its range of products, services and integrated technologies fuel active lifestyles in orthopedics and beyond. Enovis Corporation, formerly known as Colfax Corporation, is based in Wilmington, DE. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| GE HealthCare Technologies (GEHC) | United States | $39.354B | 21.89 |
| Inspire Medical Systems (INSP) | United States | $7.194B | 0.00 |
| IRhythm Technologies (IRTC) | United States | $3.483B | 0.00 |
| Axonics (AXNX) | United States | $3.401B | 0.00 |
| 10x Genomics (TXG) | United States | $3.288B | 0.00 |
| Azenta (AZTA) | United States | $2.910B | 237.18 |
| Olink Holding AB (publ) (OLK) | Sweden | $2.840B | 0.00 |
| Hims & Hers Health (HIMS) | United States | $2.678B | 0.00 |
| Privia Health (PRVA) | United States | $2.167B | 96.11 |
| Schrodinger (SDGR) | United States | $1.733B | 0.00 |
| Omnicell (OMCL) | United States | $1.279B | 31.30 |
| Phreesia (PHR) | United States | $1.162B | 0.00 |
| Definitive Healthcare (DH) | United States | $0.823B | 0.00 |
| Standard BioTools (LAB) | United States | $0.708B | 0.00 |
| Fulgent Genetics (FLGT) | United States | $0.601B | 0.00 |
| Talkspace (TALK) | United States | $0.527B | 0.00 |
| Health Catalyst (HCAT) | United States | $0.353B | 0.00 |
| Clover Health Investments (CLOV) | United States | $0.337B | 0.00 |
| SOPHiA GENETICS SA (SOPH) | Switzerland | $0.328B | 0.00 |
| Pulmonx (LUNG) | United States | $0.281B | 0.00 |
| Butterfly Network (BFLY) | United States | $0.162B | 0.00 |
| American Well (AMWL) | United States | $0.153B | 0.00 |
| MSP Recovery (LIFW) | United States | $0.141B | 0.00 |
| P3 Health Partners (PIII) | United States | $0.141B | 0.00 |
| Augmedix (AUGX) | United States | $0.139B | 0.00 |
| Outset Medical (OM) | United States | $0.124B | 0.00 |
| TruBridge (TBRG) | United States | $0.118B | 5.03 |
| 111 (YI) | China | $0.086B | 0.00 |
| SHL Telemedicine (SHLT) | Israel | $0.082B | 0.00 |
| Future Health ESG (FHLT) | United States | $0.073B | 0.00 |
| HeartBeam (BEAT) | United States | $0.053B | 0.00 |
| Zepp Health (ZEPP) | China | $0.052B | 0.00 |
| EUDA Health Holdings (EUDA) | Singapore | $0.048B | 0.00 |
| ImmunoPrecise Antibodies (IPA) | Canada | $0.035B | 0.00 |
| Movano (MOVE) | United States | $0.026B | 0.00 |
| Bullfrog AI Holdings (BFRG) | United States | $0.023B | 0.00 |
| Cue Health (HLTH) | United States | $0.022B | 0.00 |
| Akili (AKLI) | United States | $0.019B | 0.00 |
| Streamline Health Solutions (STRM) | United States | $0.019B | 0.00 |
| Strata Skin Sciences (SSKN) | United States | $0.018B | 0.00 |
| CareCloud (CCLD) | United States | $0.017B | 0.00 |
| ETAO (ETAO) | United States | $0.015B | 0.00 |
| Biotricity (BTCY) | United States | $0.012B | 0.00 |
| Transgenomic (PRPO) | United States | $0.009B | 0.00 |
| HeartSciences (HSCS) | United States | $0.006B | 0.00 |
| Syra Health (SYRA) | United States | $0.006B | 0.00 |
| Predictive Oncology (POAI) | United States | $0.006B | 0.00 |
| Healthcare Triangle (HCTI) | United States | $0.006B | 0.00 |
| Zhongchao (ZCMD) | China | $0.003B | 0.00 |
| Tivic Health Systems (TIVC) | United States | $0.002B | 0.00 |
| Centogene (CNTG) | Germany | $0.000B | 0.00 |
| MDxHealth SA (MDXH) | Belgium | $0.000B | 0.00 |
| Mobile-health Network Solutions (MNDR) | Singapore | $0.000B | 0.00 |
| Nyxoah SA (NYXH) | Belgium | $0.000B | 0.00 |